Cardiovascular and renal protective effects of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation

AIM: Data on the use of non-vitamin K antagonist oral anticoagulants (NOACs) in relation to the risk of cardiovascular (CV) disease and renal protection among patients with atrial fibrillation (AF), are relatively sparse. We aimed to compare the effectiveness and safety of NOACs with those of warfar...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seong Huan, Kim, Mina, Kim, Hoseob, Kim, Dae-Hyeok, Baek, Yong-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560050/
https://www.ncbi.nlm.nih.gov/pubmed/36227869
http://dx.doi.org/10.1371/journal.pone.0275103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560050/
https://www.ncbi.nlm.nih.gov/pubmed/36227869
http://dx.doi.org/10.1371/journal.pone.0275103

Ejemplares similares